Psychotropic drug prescribing in child and adolescent learning disability psychiatry

Abstract

This postaL questionnaire study investigated the prescribing practices of a group of senior British psychiatrists who have responsibilities for children and adoLescents with learning disabilities (mental retardation). The study revealed that all of the clinicians surveyed (n = 16) were prescribing psychotropic medication; psychostimulants and major tranquillizers represented the most frequently prescribed classes and, respectively, methylphenidate, risperidone, melatonin, sodium valproate and carbamazepine were the most frequently employed specific agents. Most patients were receiving monotherapy. Many (14/16) clinicians reported difficulties in shared-care prescribing arrangements with General Practitioners. The study concludes that psychopharmacology is an established part of the psychiatric management of learning disabled children but acknowledges the need for the elaboration of clinical governance standards to this area of practice.

Keywords

paediatric psychopharmacology prescribing autism mental retardation

Get full access to this article

View all access options for this article.

References

Aman M.G. , Buican B. , Arnold L.E. (2003) Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies . J Child Adolesc Psychopharmacology 13: 29—40

Aman M.G. , Smedt G.D. , Derivan A. , Lyons B. , Findling R.L. (2002) Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviours in children with subaverage intelligence . Am J Psychiatry 159: 1337—1346

American Association on Mental Retardation ( 2000) Expert Consensus Guidelines Series: treatment of psychiatric and behavioral problems in mental retardation . Am J Mental Retardation 105: 178—188

American Psychiatric Association (1994) Diagnostic and Statistical Manual for Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC

Bramble D. (1997) The use of psychostimulants by British child psychiatrists . Child Psychol Psychiatry Rev 2: 159—162

Bramble D. (1999) Stimulants and British learning disability psychiatrists . J Applied Res Intellectual Disabilities 12: 157—163

Bramble D. , Feehan C. (2005) Psychiatrists' use of melatonin with children. Child Adolesc Mental Health 10: 145—149

British National Formulary 50 (2005) Section 4.3.3: Selective serotonin reuptake inhibitors. British Medical Association & Royal Pharmaceutical Society of Great Britain : 202—205

British National Formulary for Children (2005 ) Section 4.3.3: Selective serotonin re-uptake inhibitors. British Medical Association & Royal Pharmaceutical Society of Great Britain : 211—213

10.

Cheng-Shannon J. , McGough J.J. , Pataki C. , McCracken J.T. (2004) Second-generation antipsychotic medications in children and adolescents . J Child Adolesc Psychopharmacology 14: 372—394

11.

Clarke A.F. (2004) Incidences of new prescribing by British child and adolescent psychiatrists: a prospective study over 12 months . J Psychopharmacology 18: 115—120

12.

Committee on Safety of Medicines. (2003) Use of selective serotonin reuptake inhibitors (SSRIs) in children and adolescents with major depressive disorder (MDD). Available online at www.mca.gov/uk/aboutagency/regframework/csm/csmhome.html

13.

Department of Health (2004) Medicines Standard: National Service Framework for Children, Young People and Maternity Services. Department of Health Publications, (http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/ChildrenServices/fs/en )

14.

McBride P.A. , Anderson G.M. , Hertzig M.E. (1998) Effects of diagnosis, race and puberty on platelet serotonin levels in autism and mental retardation . J Am Acad Child Adolesc Psychiatry 37: 767—776

15.

Murray M L. , de Vries C S. , Wonk I C K. (2004) A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database . Arch Dis Child 89: 1098—1102

16.

Santosh P. , Baird G. (1999) Psychopharmacotherapy in children and adults with learning disability . Lancet 354: 233—42

17.

Silva R.R. , Munoz D.M. , Alpert A. (1996) Carbamazepine use in children and adolescents with features of attention deficit hyperactivity disorder: a meta-analysis . J Am Acad Child Adolesc Psychiatry 35: 352—358

18.

Wong I C K , Murray M.L. , Camilleri-Novak D. , Stephens P. (2004) Increased prescribing trends of paediatric psychotropic medications . Arch Dis Child 89: 1131—1132